The Week Ahead: Fed...
Health Care: Health Services
AtriCure Inc. (ATRC: NASDAQ)
$8.80 -0.19 | -2.11%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 15.40 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 49.90 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 15.50 | 12.50 |
| Beta | 1.29 | 0.77 | 0.98 |
| Price to Sales (TTM) | 2.19 | 1.97 | 1.42 |
| Price to Book (MRQ) | 9.90 | 2.14 | 2.41 |
| Price to Tangible Book (MRQ) | 9.93 | 7.49 | 5.08 |
| Price to Cash Flow (TTM) | -38.80 | 10.50 | 9.80 |
| Price to Free Cash Flow (TTM) | -36.30 | 58.60 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 1.10 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 1.00 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 8.98 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 17.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 11.80 | 10.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 9.10 | -11.40 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 8.12 | 12.06 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 8.70 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 8.70 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -12.65 | 6.33 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 2.10 | 1.80 | 1.10 |
| Current Ratio (MRQ) | 2.80 | 2.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.54 | 0.32 | 0.82 |
| Total Debt to Equity (MRQ) | 0.68 | 0.34 | 0.96 |
| Interest Coverage (TTM) | n.a. | 11.50 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 75.40 | 59.90 | 46.90 |
| Gross Margin - 5 Yr Avg | 80.60 | 59.90 | 47.70 |
| EBITD Margin (TTM) | -4.70 | 23.80 | 18.90 |
| EBITD - 5 Yr Avg | -13.65 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -8.70 | 15.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | -16.80 | 11.90 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -0.09 | 0.13 | 0.09 |
| Net Profit Margin - 5 Yr Avg | -16.80 | 8.70 | 7.00 |
| Return on Assets (TTM) | -15.90 | 7.60 | 3.10 |
| Return on Assets - 5 Yr Avg | -24.60 | 5.20 | 2.50 |
| Return on Investment (TTM) | -25.00 | 10.20 | 7.90 |
| Return on Investment - 5 Yr Avg | -36.50 | 7.20 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 276,007.00 | 296,359.00 | 449,376.00 |
| Net Income/Employee (TTM) | -24,176.00 | 40,294.00 | 39,003.00 |
| Receivable Turnover (TTM) | 7.00 | 6.00 | 7.60 |
| Inventory Turnover (TTM) | 2.50 | 2.90 | 8.30 |
| Asset Turnover (TTM) | 1.80 | 0.60 | 0.40 |
Portfolios with ATRC
- Portfolio NameUser Type
- ContributorBarrington's Best Stock Pic...
- ContributorBarrington's Updated Best S...
- Userfjknight Portfolio 1
- UserRAPTOR SPRTD RED -0311081629
- Useramarmaharaj Portfolio 1
- UserBarron's Research Reports 5...
- Userralphmalph Portfolio 1
- Useryvebee1
- UserSmall Cap Healthcare
Latest ATRC Headlines from TheStreet
- AtriCure's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.03.12 | 04:05 pm
- AtriCure's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.27.12 | 07:02 pm
- Barrington's Best Stock Picks for 2012 01.12.12 | 05:01 am
- AtriCure Update On DEEP AF Feasibility Trial - Call Transcript 12.11.11 | 04:12 pm
- AtriCure's CEO Hosts Update Call On DEEP AF Feasibility Trial - Conference Call Transcript 12.11.11 | 04:12 pm
- AtriCure's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.01.11 | 05:11 pm
- AtriCure's CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.02.11 | 05:08 pm
- AtriCure CEO Discusses Q1 2011 Results - Earnings Call Transcript 05.04.11 | 03:05 pm
- Barrington Updates Best Stock Picks for 2011 04.12.11 | 06:04 am
- AtriCure, Inc. CEO Discusses Q4 2010 Results - Earnings Call Transcript 02.16.11 | 03:02 pm
Press Releases for ATRC
- AtriCure Reports First Quarter 2012 Financial Results - Business Wire 05.02.12 | 04:05 pm
- AtriCure To Announce First Quarter 2012 Financial Results - Business Wire 04.23.12 | 09:04 am
- AtriCure To Present At 24th Annual Roth Conference - Business Wire 03.06.12 | 08:03 am
- AtriCure Reports Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.27.12 | 04:02 pm
- AtriCure To Announce Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.21.12 | 03:02 pm
- AtriCure Announces February Investor Conference Schedule - Business Wire 02.09.12 | 12:02 pm
- AtriCure’s Synergy Ablation System Receives FDA Approval For The Treatment Of Atrial Fibrillation - Business Wire 12.16.11 | 08:12 am
- Update On AtriCure’s DEEP AF Feasibility Trial - Business Wire 11.17.11 | 08:11 am
- AtriCure Announces Upcoming Investor Conference Schedule - Business Wire 11.10.11 | 11:11 am
- AtriCure Reports Third Quarter 2011 Financial Results - Business Wire 11.01.11 | 08:11 am
Partner Headlines for ATRC
- Piper Jaffray Gives Insight to Medical Technology Industry Overview - Benzinga 01.17.12 | 09:01 am
- Will Barrington's Best Stock Picks for 2011 Deliver? - Seeking Alpha 04.18.11 | 07:04 am
- UPDATE 1-AtriCure's heart device gets FDA approval; shares up - Reuters 06.14.10 | 05:06 pm
